SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000929638-24-002235
Filing Date
2024-06-20
Accepted
2024-06-20 16:01:42
Documents
2
Group Members
BIHUA CHENCORMORANT GLOBAL HEALTHCARE GP III, LLCCORMORANT GLOBAL HEALTHCARE GP IV, LLCCORMORANT GLOBAL HEALTHCARE GP V, LLCCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LPCORMORANT PRIVATE HEALTHCARE FUND III, LPCORMORANT PR

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 157755
2 JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS exhibit99-1.htm EX-99.1 23743
  Complete submission text file 0000929638-24-002235.txt   183684
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

IRS No.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Subject) CIK: 0002012593 (see all company filings)

IRS No.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94532 | Film No.: 241056124
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)